Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Boundless Bio, Inc. (BOLD) had Tangible Shareholders Equity of $86.38M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.55M |
|
-- |
|
-- |
|
$14.47M |
|
$-14.47M |
|
$0.92M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-13.55M |
|
$-14.47M |
|
$-14.19M |
|
22.41M |
|
22.41M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$94.62M |
|
$2.94M |
|
$46.35M |
|
$140.97M |
|
$9.58M |
|
$45.00M |
|
$45.00M |
|
$54.59M |
|
$86.38M |
|
|
Tangible Shareholders Equity |
$86.38M |
$86.38M |
|
22.41M |
|
| Cash Flow Statement Financials | |
$-14.97M |
|
$14.59M |
|
-- |
|
$18.43M |
|
$18.04M |
|
$-0.39M |
|
$1.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.87 |
|
-- |
|
-- |
|
0.34 |
|
0.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.69% |
|
-15.69% |
|
-9.62% |
|
-10.32% |
|
$3.86 |
|
$-0.67 |
|
$-0.67 |
|